Deutsche Plattform NanoBioMedizin (DP-NBM)

Deutsche Plattform NanoBioMedizin (DP-NBM) is at the forefront of nanotechnology research, driving innovation and progress in the field of biomedicine. Located at Theodor-Heuss-Allee 25 in Frankfurt am Main, Germany, DP-NBM fosters collaboration between technology developers from material sciences, chemistry, biology, and physics with medical professionals including pharmacists, clinicians, and industrial companies.

DP-NBM is committed to integrating nanotechnology into biomedical applications, also known as NanoBioMedicine, which requires new interdisciplinary research concepts and value chains. The platform aims to facilitate the development of tailored innovations for patients, enhancing the understanding of disease causes and processes through detailed analysis and targeted treatments.

Deutsche Plattform NanoBioMedizin (DP-NBM) strives to promote research from nanomanufacturing to clinical applications, enhancing Germany's scientific and economic potential in NanoBioMedicine through sustainable research topics and structures. This initiative aims to strengthen Germany's leading position in future technologies. We invite the management of Deutsche Plattform NanoBioMedizin (DP-NBM) to create a customized and exclusive company showcase and product listing on our platform to further enhance your visibility and reach.